E-Support Groups in Multiple Sclerosis
A Randomized Controlled Trial of e-Support in Persons With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 7 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- e-Support group
Placebo
- e-Journaling placebo
What it measured
Main measures
Percentage of enrolled participants who completed follow-up questionnaires
12 weeks
FeasibilityChange in UCLA Loneliness Scale total score (please note that the official name of the scale is the UCLA Loneliness Scale).
Baseline, 12 weeks (immediate follow-up)
Other measures (2)
Change in overall depression [Patient Health Questionnaire (PHQ-9)] total score
Baseline, 12 weeks
Mood and sleepChange in overall Functional Assessment of Multiple Sclerosis Quality of Life (FAMS QoL) score
Baseline, 12 weeks
FatigueWalking and mobilityQuality of life (reported by participants)
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Diagnosis of MS (any disease type) * Age 18 or over * Willingness to sign informed consent document
Exclusion criteria
* Unable to obtain access to the internet
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Primary objectives: * To determine the feasibility of program (80% retained with 75% overall attendance, and completed immediate follow-up questionnaires from 75% of participants). * To determine the efficacy of program (evaluated by decreased loneliness, operationalized as decreased total score on the UCLA Loneliness Scale from pre to post intervention). Secondary objective: * To determine whether program will affect depression and quality of life.
Loading reviews and guidelines…
History
Started
May 2018
Main results due
Apr 2019
Finished
Jun 2019